Tseng S.-H.Lee C.-M.Lin T.-Y.SHAN-CHWEN CHANGChuang Y.-C.Yen M.-Y.Hwang K.-P.Leu H.-S.Yen C.-C.Chang F.-Y.2020-12-302020-12-3020121684-1182https://www.scopus.com/inward/record.uri?eid=2-s2.0-84859846731&doi=10.1016%2fj.jmii.2012.03.007&partnerID=40&md5=40657fa4dc053ac43dba98ee71412e7dhttps://scholars.lib.ntu.edu.tw/handle/123456789/536092Multi-drug-resistant organisms are increasingly recognized as a global public health issue. Healthcare-associated infection and antimicrobial resistance are also current challenges to the treatment of infectious diseases in Taiwan. Government health policies and the health care systems play a crucial role in determining the efficacy of interventions to contain antimicrobial resistance. National commitment to understand and address the problem is prerequisite. We analyzed and reviewed the antibiotic resistance related policies in Taiwan, USA, WHO and draft antimicrobial stewardship program to control effectively antibiotic resistance and spreading in Taiwan. Antimicrobial stewardship program in Taiwan includes establishment of national inter-sectoral antimicrobial stewardship task force, implementing antimicrobial-resistance management strategies, surveillance of HAI and antimicrobial resistance, conducting hospital infection control, enforcement of appropriate regulations and audit of antimicrobial use through hospital accreditation, inspection and national health insurance payment system. No action today, no cure tomorrow. Taiwan CDC would take a multifaceted, evidence-based approach and make every effort to combat antimicrobial resistance with stakeholders to limit the spread of multi-drug resistant strains and to reduce the generation of antibiotic resistant bacteria in Taiwan. ? 2012.Antimicrobial resistance; Antimicrobial stewardship program(ASP); Healthcare-associated infection (HAI); Multi-drug-resistant organisms(MDROs)[SDGs]SDG3antiinfective agent; accreditation; antibiotic resistance; bacterial strain; evidence based medicine; government; health care policy; health care system; health program; hospital infection; human; infection control; multidrug resistance; nonhuman; review; Taiwan; United States; world health organization; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Drug Utilization; Health Policy; Humans; Taiwanreview10.1016/j.jmii.2012.03.00722483434